SCOR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SCOR is not a good buy right now. With no Intellectia buy signals, weakening profitability in the latest quarter, and a short-term setup that looks mixed-to-soft (negative MACD momentum and a statistically negative 1-month outlook), the risk/reward is unattractive for an impatient buyer. I would avoid new entries here and would sell/step aside unless it cleanly reclaims resistance and momentum turns up.
Trend/Momentum: Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), which suggests the broader trend has been constructive. However, momentum is currently fading: MACD histogram is below zero (-0.0276) and negatively expanding, pointing to increasing downside momentum/weakening upside follow-through. RSI(6) 46.25 is neutral, offering no oversold bounce signal.
Key levels: Price is sitting near the pivot (8.676). Immediate support is S1 ~8.174 (then S2 ~7.864). Immediate resistance is R1 ~9.178 (then R2 ~9.488). A clean break/hold above ~9.18 would improve the technical picture; losing ~8.17 increases downside risk.
Pattern-based forecast: Similar candlestick-pattern analysis implies a higher chance of small gains near-term (+2.2% next day, +4.39% next week) but a negative next-month expectation (-7.71%), which aligns with the weakening MACD.
Intellectia Proprietary Trading Signals
Technicals still show a constructive longer-term structure via bullish moving averages (SMA stack).
Short-term statistical/pattern read points to potential near-term upside (next day/week positive expectation).
Revenue slightly up YoY in 2025/Q3 (+0.48%), indicating some top-line stability.
Hedge funds and insiders: Neutral (no significant recent trend flagged).
Gross margin slipped YoY (to 39.92, -1.09% YoY), suggesting margin pressure.
Latest quarter: 2025/Q3. Revenue increased to $88.906M (+0.48% YoY), but profitability worsened materially: Net Income fell to -$4.518M (-93.07% YoY) and EPS to -0.86 (-93.28% YoY). Gross margin declined to 39.92% (-1.09% YoY). Overall: modest top-line growth but accelerating losses and slightly weaker margins—an unfavorable growth-quality mix for buying now.
No analyst rating/price target change data was provided, so a recent trend in Wall Street upgrades/downgrades or target revisions cannot be assessed from the dataset. Based on the available data, the key 'pro' case would be the bullish longer-term moving-average structure and slight revenue growth; the key 'con' case is sharply worsening earnings and deteriorating momentum.
